UK scientists at Oxford University are rapidly developing an experimental Ebola vaccine, potentially ready for clinical trials in two to three months, to combat the current outbreak in the Democratic Republic of Congo.

• The outbreak has caused 750 suspected cases and 177 deaths.
• The vaccine utilizes the same adaptable ChAdOx1 technology previously used for Covid-19.
• This new vaccine targets the rare Bundibugyo species of Ebola, for which no proven vaccine currently exists, though the World Health Organization (WHO) has noted a lack of animal data supporting its effectiveness yet.